ASSOCIATION BETWEEN CHROMOSOME-11Q13 AMPLIFICATION AND PROGNOSIS OF PATIENTS WITH ESOPHAGEAL CARCINOMAS

被引:25
作者
MORI, M
TOKINO, T
YANAGISAWA, A
KANAMORI, M
KATO, Y
NAKAMURA, Y
机构
[1] JAPANESE FDN CANC RES,INST CANC,DEPT BIOCHEM,KAMI IKEBUKURO 1-37-1,TOSHIMA KU,TOKYO 170,JAPAN
[2] NATL INST HLTH,DEPT BIOSTAT & HUMAN GENET,TOKYO 141,JAPAN
[3] JAPANESE FDN CANC RES,INST CANC,DEPT PATHOL,TOSHIMA KU,TOKYO 170,JAPAN
关键词
D O I
10.1016/0959-8049(92)90109-F
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ninety pairs of normal and tumour tissue DNAs were isolated from paraffin-embedded blocks of advanced oesophageal carcinoma cases and examined for gene amplification at chromosome 11q13 by dot-blot hybridisation using the int-2 gene as a probe. 22 of 90 carcinomas (24%) showed more than two times amplification. Although no significant correlation was observed between gene amplification and histological type or metastasis to lymph node, a tendency for deeper invasion to be associated with more frequent amplification was observed. In relation to prognosis, patients with amplification had a lower survival rate than those without amplification. This tendency was evident both in the group with well differentiated type carcinoma and in the group which had no metastasis to lymph node. Thus, gene amplification of the int-2 locus may be a useful prognostic factor.
引用
收藏
页码:755 / 757
页数:3
相关论文
共 14 条
[11]   HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J].
SLAMON, DJ ;
CLARK, GM ;
WONG, SG ;
LEVIN, WJ ;
ULLRICH, A ;
MCGUIRE, WL .
SCIENCE, 1987, 235 (4785) :177-182
[12]  
SOMERS KD, 1990, ONCOGENE, V5, P915
[13]  
TSUDA T, 1989, CANCER RES, V49, P5505
[14]   HUMAN HST1 (HSTF1) GENE MAPS TO CHROMOSOME BAND-11Q13 AND COAMPLIFIES WITH THE INT2 GENE IN HUMAN CANCER [J].
YOSHIDA, MC ;
WADA, M ;
SATOH, H ;
YOSHIDA, T ;
SAKAMOTO, H ;
MIYAGAWA, K ;
YOKOTA, J ;
KODA, T ;
KAKINUMA, M ;
SUGIMURA, T ;
TERADA, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4861-4864